School of Preclinical Medicine, Guangxi Medical University, 22 ShuangYong Road, Nanning, 530021, Guangxi, China.
Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, 530028, Guangxi, China.
Virus Genes. 2023 Jun;59(3):359-369. doi: 10.1007/s11262-023-01980-6. Epub 2023 Feb 25.
Genotype I of hepatitis B virus (HBV) was proposed recently following sequencing of complete HBV genomes from Vietnam and Laos. However, its long-term molecular evolution is unknown. The objectives of this study were to study the molecular evolution of this genotype from an asymptomatic HBsAg carrier from the Long An cohort over a 15-year period was studied using both NGS and clone-based sequencing. The number of complete genome sequences obtained in 2004, 2007, 2013, and 2019 are 17, 20, 19, and 10, respectively. All strains belong to subgenotype I1, except for six (five from 2007 and one from 2019) and 8 further strains from 2007 which form a cluster branching out from other subgenotype I sequences, supported by a 100% bootstrap value. Based on complete genome sequences, all of the estimated intragroup nucleotide divergence values between these strains and HBV subgenotypes I1-I2 exceed 4%. These strains are recombinants between genotype I1 and subgenotype C but the breakpoints vary. The median intrahost viral evolutionary rate in this carrier was 3.88E-4 substitutions per site per year. The Shannon entropy (Sn) ranged from 0.55 to 0.88 and the genetic diversity, D, ranged from 0.0022 to 0.0041. In conclusion, our data provide evidence of novel subgenotypes. Considering that the 8 strains disappeared after 2007, while one of the 6 strains appears again in 2019, we propose these 6 strains as a new subgenotype, provisionally designated HBV subgenotype I3 and the 8 strains as aberrant genotype.
乙型肝炎病毒(HBV)基因型 I 是在对越南和老挝的完整 HBV 基因组进行测序后最近提出的。然而,其长期的分子进化尚不清楚。本研究的目的是研究来自龙安队列的无症状 HBsAg 携带者在 15 年内的这种基因型的分子进化,使用 NGS 和基于克隆的测序。2004 年、2007 年、2013 年和 2019 年获得的完整基因组序列数分别为 17、20、19 和 10。除了 6 个(2007 年 5 个和 2019 年 1 个)和 2007 年的 8 个进一步的菌株,所有菌株均属于亚基因型 I1,这 8 个菌株从其他亚基因型 I 序列分支出来,支持值为 100%。基于完整基因组序列,这些菌株与 HBV 亚基因型 I1-I2 之间的所有估计的组内核苷酸差异值均超过 4%。这些菌株是基因型 I1 和亚基因型 C 之间的重组体,但断点不同。该携带者体内病毒的中位进化率为每年每位点 3.88E-4 个替换。Shannon 熵(Sn)范围为 0.55 至 0.88,遗传多样性(D)范围为 0.0022 至 0.0041。总之,我们的数据提供了新的亚基因型的证据。考虑到 2007 年后 8 个菌株消失,而其中 6 个菌株中的 1 个在 2019 年再次出现,我们将这 6 个菌株作为新的亚基因型,暂定命名为 HBV 亚基因型 I3,8 个菌株为异常基因型。